logo-loader
RNS
viewAlliance Pharma PLC

Total Voting Rights

/**/ h1{margin-top:3.0pt;margin-right:0cm;margin-bottom:3.0pt;margin-left:36.0pt;text-align:justify;text-indent:-36.0pt;line-height:150%;font-size:11.0pt;font-family:"Sabon","serif";}h2{margin-top:3.0pt;margin-right:0cm;margin-bottom:3.0pt;margin-left:36.0pt;text-align:justify;text-indent:-36.0pt;line-height:150%;font-size:11.0pt;font-family:"Sabon","serif";font-weight:normal;}h3{margin-top:3.0pt;margin-right:0cm;margin-bottom:3.0pt;margin-left:72.0pt;text-align:justify;text-indent:-36.0pt;line-height:150%;font-size:11.0pt;font-family:"Sabon","serif";font-weight:normal;}h4{margin-top:3.0pt;margin-right:0cm;margin-bottom:3.0pt;margin-left:108.0pt;text-align:justify;text-indent:-36.0pt;line-height:150%;font-size:11.0pt;font-family:"Sabon","serif";font-weight:normal;}h5{margin-top:3.0pt;margin-right:0cm;margin-bottom:3.0pt;margin-left:144.0pt;text-align:justify;text-indent:-36.0pt;line-height:150%;font-size:11.0pt;font-family:"Sabon","serif";font-weight:normal;}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .y{size:595.3pt 841.9pt;margin:2.0cm 70.8pt 72.0pt 72.0pt;}div.y{}table.av{width:16.0cm;margin-left:-5.4pt;border-collapse:collapse}tr.ao{page-break-inside:avoid}td.as{width:191.9pt;padding:0cm 5.4pt 0cm 5.4pt}p.a,li.a,div.a{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Arial","sans-serif";color:#003333;font-weight:bold;}span.at{font-size:10.0pt;font-family:"Segoe UI","sans-serif"; color:windowtext}td.ap{width:240.1pt;padding:0cm 5.4pt 0cm 5.4pt}p.aw{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Arial","sans-serif";color:#003333;font-weight:bold;text-align: right}span.ar{font-size:10.0pt;font-family:"Segoe UI","sans-serif";color:windowtext} h1.al{margin:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:normal}span.am{font-size:12.0pt;font-family:"Segoe UI","sans-serif"}p.ax{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Arial","sans-serif";color:#003333;font-weight:bold;text-align: center}h1.ai{line-height: normal; margin: 0cm; margin-bottom: .0001pt; text-align: center; text-indent: 0cm}span.aj{font-size:12.0pt;font-family: "Segoe UI","sans-serif"}span.ah{font-size:10.0pt;font-family:"Segoe UI","sans-serif";color:windowtext; font-weight:normal}p.ay{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Arial","sans-serif";color:#003333;font-weight:bold;text-align:justify}span.ag{font-size:10.0pt; font-family:"Segoe UI","sans-serif";color:windowtext;font-weight:normal}span.ae{font-size:10.0pt; font-family:"Segoe UI","sans-serif";color:#2E74B5}span.ad{font-size:10.0pt;font-family:"Segoe UI","sans-serif"; color:windowtext;font-weight:normal} span.ac{font-size:10.0pt;font-family:"Segoe UI","sans-serif"; color:#2E74B5}span.ab{font-size:10.0pt;font-family:"Segoe UI","sans-serif";font-weight:normal}span.aa{font-size:9.0pt;font-family:"Segoe UI","sans-serif"; color:windowtext}span.z{font-size:9.0pt;font-family:"Segoe UI","sans-serif"; color:windowtext;font-weight:normal} /**/
RNS Number : 5209V
Alliance Pharma PLC
03 December 2019
 

For immediate release

3rd December 2019

 

 

 

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Total Voting Rights

 

Alliance Pharma plc (AIM: APH), the international healthcare group, makes the following notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1.

 

As at 30 November 2019 the Company's issued share capital consists of 526,576,586 Ordinary Shares of 1p each.

 

The total number of voting rights in the Company is 526,576,586 and this figure may be used by shareholders as the denominator for the calculations by which they should determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information:

 

Alliance Pharma plc                                                                                          + 44 (0) 1249 466966

Peter Butterfield, Chief Executive Officer

Andrew Franklin, Chief Financial Officer

www.alliancepharma.co.uk 

 

Buchanan                                                                                                           + 44 (0) 20 7466 5000

Mark Court / Sophie Wills / Hannah Ratcliff

 

Numis Securities Limited                                                                                 + 44 (0) 20 7260 1000

Nominated Adviser: Freddie Barnfield

Corporate Broking: James Black

 

Investec Bank plc                                                                                              +44 (0) 20 7597 5970

Corporate Finance: Daniel Adams / Ed Thomas

Corporate Broking: Patrick Robb / Tejas Padalkar

 

Notes to editors:

 

About Alliance Pharma

 

Alliance, founded in 1998, is an international specialty pharmaceutical group based in Chippenham, Wiltshire, UK. The Group has sales in more than 100 countries worldwide via direct sales, joint ventures and a wide network of distributors.  Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Group continues to explore opportunities to expand its product portfolio.

 

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVREAAADEEDNFFF

Quick facts: Alliance Pharma PLC

Price: 87

Market: AIM
Market Cap: £460.58 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

'It's never been so busy and exciting', says Alliance Pharma PLC CEO

Alliance Pharma plc (LON:APH) said revenues had more than doubled and trading profits for the year to the end of December were in line with City forecasts as it provided investors with a progress report. The speciality pharma company said it expects sales to be £97.5mln - up from £48.3mln...

on 24/1/17

RNS

Notification of Major Holdings

4 days, 17 hours ago

Full Year Trading Update

4 days, 22 hours ago

Block Listing Six Monthly Return

2 weeks, 6 days ago

Total Voting Rights

3 weeks, 3 days ago

NOTIFICATION OF MAJOR HOLDINGS

3 weeks, 3 days ago

Director's Dealing

on 6/12/19